A Case-Control Study of the Association Between Karenia Brevis (Red Tide) and Biliary Atresia ============================================================================================= * Rita Wyrebek * Jamie L Fierstein * Rebecca G. Wells * Joana Machry * Sara Karjoo ## Abstract **Objective** The study objective was to evaluate the association between maternal *Karenia brevis (K. brevis)* exposure during pregnancy and the prevalence of biliary atresia (BA) in offspring. Study Design This was a hospital-based, case-control study in which cases were infants diagnosed with BA at Johns Hopkins All Children’s Hospital from October 2001 to December 2019. Controls were matched 4:1 by age, randomly selected from healthy infants hospitalized during the study period for common pediatric diagnoses. Infants were excluded if they had congenital anomalies and/or were non-Florida residents. Gestational *K. brevis* exposure levels (cells/liter) were determined from Florida Fish and Wildlife Conservation Commission exposure data at 10- and 50-mile radii from the mother’s zip code of residence. Multivariable conditional logistic regression determined adjusted odds of BA in offspring based on maternal gestational *K. brevis* exposure. **Results** Of 38 cases and 152 controls, no significant inter-group differences were observed in race/ethnicity, season of birth or coastal residence. Median gestational exposure at the 10-mile radius was 0 cells/liter in both groups. A greater proportion of cases had no *K. brevis* exposure (63.2%, n = 24) in comparison to controls (37.5%, n = 57; p = .04) at a 10-mile radius. At the 50-mile radius, cases had a peak median exposure at 6 months of gestation compared to controls’ peak at 9 months. After adjustment for sex, seasonality, race/ethnicity, and coastal residence, there was no significant association between BA and maximum *K. brevis* exposure per trimester of pregnancy at the 10-or 50-mile radius. **Conclusion** We observed no association between gestational *K. brevis* (cells/liter) exposure at a 10- and 50-mile radius from maternal zip code of residence and BA in offspring. **Key points** * Environmental toxins may cause biliary atresia (BA) * Red tide is caused by algal blooms (*Karenia brevis)* * Red tide is debilitating to marine wildlife * Gestational exposure to *K. brevis* does not cause BA Key words * neonatal cholangiopathy * brevetoxin * environmental toxins * algal bloom * gestational exposure ## INTRODUCTION Prenatal exposure to environmental toxins 1–5 is one of the possible mechanisms underlying the development of biliary atresia (BA), a devastating, progressive neonatal cholangiopathy characterized by extra-hepatic bile duct obstruction 6. Liver development begins as early as the second week of embryonic life with bile ducts appearing by the 8th week of life 7,8, during which time the fetus is especially vulnerable to toxic insults. The underlying pathophysiology of BA is unknown, with many proposed etiologies (genetic, infectious, toxin-mediated). Environmental toxins have been previously implicated in BA development in animals 1–4. Recently, a plant isoflavonoid named biliatresone was found to cause a BA-like disease in livestock 4,5,9. There may be similar toxins in the environment that mimic the effects and properties of biliatresone 10. In our institutional experience, we noticed significant annual fluctuation in both biliary atresia cases as well as severity of red tide outbreaks in the Southwest Gulf of Mexico (Figure 1) prompting the hypothesis that there could be a relationship between the two phenomena. There have been few studies exploring the association between environmental toxins and development of BA in humans 10. Red tide blooms, caused by the dinoflagellate *Karenia brevis*, occur in the late summer and early fall but can last days, weeks or months 11. *K. brevis* produce brevetoxins, which are lipophilic, cyclic polyethers 12–16 that cause severe morbidity and mortality among wildlife 12,15,17–26, developmental anomalies in fish embryos 27,28 and respiratory toxicity, gastrointestinal symptoms, and neurotoxicity in humans 29–32. Brevetoxins impair immune system function 13 and disturb DNA structure 27,33. Across multiple species, brevetoxins are concentrated in the muscles, intestine and notably, the liver, with primary elimination via biliary excretion 13,15,16,19,21,23,33,34 and with toxic effects that appear to persist beyond a single exposure 13. ![Figure 1:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/26/2022.10.24.22279447/F1.medium.gif) [Figure 1:](http://medrxiv.org/content/early/2022/10/26/2022.10.24.22279447/F1) Figure 1: *K. brevis* (cells/liter) levels as collected and reported at multiple timepoints per annum by the Florida Fish and Wildlife Conservation Commission with superimposed incidence of biliary atresia cases at Johns Hopkins All Children’s Hospital between 1986 and 2019. We therefore conducted a case-control study to evaluate whether maternal exposure to *K. brevis* (cells/liter) during gestation was associated with BA in offspring. ## METHODS ### Subjects and study design This was a single-center, hospital-based, case-control study of patients seen at Johns Hopkins All Children’s Hospital from 10/2/2001 to 12/23/2019. The electronic medical record was queried for prespecified ICD-10 and ICD-9 codes indicative of BA: Q44.2, Q44.5, Q44.0, Q44.1, Q44.3, Q44.7, 751.61. Cases were infants with a diagnosis of BA confirmed after independent review of the medical records and liver biopsy pathology reports. For each case, 4 controls were individually matched by birth month and year. Controls were randomly selected from a pool of patients without a diagnosis of BA who were admitted to the hospital during the study period, and who were diagnosed with common pediatric respiratory infections (bacterial or viral), foreign body ingestions, injuries, gastrointestinal reflux, asthma or common dermatologic diseases of childhood without any documented chronic or genetic disorders or congenital anomalies. Cases and controls were excluded if they were diagnosed with Alagille syndrome, congenital heart disease with cholestasis, Down syndrome with cholestasis, neonatal cholestasis, congenital cystic adenomatoid malformation, choledochal cyst, progressive familial intrahepatic cholestasis, congenital syphilis, VACTERL syndrome, gastroschisis with cholestasis, genetic abnormalities, cryptogenic cirrhosis, Kabuki syndrome, cystic fibrosis, Caroli syndrome, Noonan syndrome, Hirschsprung with cholestasis, and other ductal problems not deemed to be BA upon pathology review. Additionally, cases and controls were excluded if they were non-Florida residents. There were no biological relationships among cases or controls. The study was approved by Johns Hopkins All Children’s Hospital Institutional Review Board (IRB00252758) prior to initiation. ### *K. brevis* exposure assessment Zip-code level *K. brevis* exposure was mapped to the patient-level for each case and control using water concentration levels routinely measured and reported in Gulf coast counties by the Florida Fish and Wildlife Conservation Commission (FWC). Zip-code level exposure data from the FWC were exported from the FWC database in 28-day increments based on a full term 40-week gestation extrapolated from the patient date of birth. Queries were exported as comma separated value spreadsheets and converted to shapefiles based on latitude and longitude using the ArcCatalog (10.7.1) “Add XY Data” tool. The shapefiles were then projected to NAD 1983 HARN Florida GDL Albers using ArcCatalog’s “Project” tool. Using patient zip codes as a proxy for residence, both 10-mile and 50-mile radii were drawn using the “Buffer” tool to assign an individual-level *K. brevis* exposure to each patient. Data were then exported for statistical analyses. ### Covariates Gender and race/ethnicity, based on self-report, were collected at hospital admission. Patients were categorized according to whether they lived within an area designated as coastal by independent determination of whether the patient’s zip code directly abutted Tampa Bay or the Gulf of Mexico. To analyze seasonality of birth, dates of birth were specified as summer (June 21 to September 21), fall (September 22 to December 20), winter (December 21 to March 19) or spring (March 20 to June 20). ### Statistical analyses Demographic characteristics were summarized with frequencies and percentages for categorical variables. Median gestational *K. brevis* exposure within a 10- and 50-mile radius of the household zip code was calculated and reported with interquartile ranges and minimum to maximum values. Maximum gestational toxin exposure was calculated and categorized using clinically relevant cut-points for descriptive purposes (i.e., none/not present: <1000 cells, low: >1,000-99,000, medium: ≥100k – 999k, high: ≥1 million), as routinely stratified by the FWC. Statistical comparisons between cases and controls were performed using Mann-Whitney *U* test for continuous variables and Chi-square or Fisher’s exact test for categorical variables as appropriate. Conditional multivariable logistic regression models matched for age were constructed to evaluate the adjusted association between maximum *K. brevis* exposure per trimester at the 10- and 50-mile radius in mothers and odds of BA in neonates. The primary independent variable, maximum gestational *K. brevis* exposure, was dichotomized into none/not present/low exposure (<1000 cells/liter to 99,000 cells/liter) and medium/high exposure (≥100k cells/liter and above). To arrive at the final multivariable models, gender, race/ethnicity, coastal residence, and season of birth were tested as potential confounders of the relationship between *K. brevis* exposure and BA using the 10% criterion for confounding. Multi-categorical covariates, including race/ethnicity and season of birth, were dichotomized for statistical efficiency. Missing data were not imputed. Adjusted odds ratios and 95% confidence intervals were calculated. Two-sided *p*-values < .05 were considered statistically significant. All analyses were conducted with Stata/SE Version 17.1 (StataCorp LLC, College Station, TX.). ### Sample Size Considerations Power was examined using PASS 16 Power Analysis and Sample Size Software (2018, NCSS, LLC; Kaysville, Utah, USA, ncss.com/software/pass). Given the lack of evidence on the relationship under study, a population standard deviation of 1.5 in the exposure as well as an R2 of 0.2 between exposure and covariates was assumed based on clinical expertise. With these considerations and a sample size of 38 cases matched to 152 controls in a 1:4 ratio, the study had an estimated 90% power to detect an odds ratio of 2.0 at a significance level of .05 utilizing conditional multivariable logistic regression. ## RESULTS ### Study population characteristics Upon query of the EMR during the study period, 109 unique patients over 521 patient encounters were identified. After inclusion/exclusion criteria were applied, there were 38 cases of BA for which 152 controls were selected. Demographic characteristics of the study population are presented in Table 1. The distribution of gender differed between cases and controls; 55.3% (n=21) of cases were female and 64.5% (n=98) of controls were male (*p*=.03). Race/ethnicity, season of birth, and coastal residence did not vary significantly between cases and controls (*p*≥ .05 for all). View this table: [Table 1.](http://medrxiv.org/content/early/2022/10/26/2022.10.24.22279447/T1) Table 1. Demographic characteristics of cases and controls ### *K. brevis* exposure in cases and controls The median gestational exposure at the 10-mile radius was 0 cells/liter among both controls (IQR: 0 to 1000.8 cells/liter) and cases (IQR: 0 to 0 cells/liter; *p*=.2). As seen in Figure 2, at the 50-mile radius, the median gestational exposure was 2000 cells/liter among both controls (IQR: 666.5 to 742500 cells/liter) and cases (IQR: 416.5 to 1063500 cells/liter; *p* >.9). Median gestational *K. brevis* exposure at the 50-mile radius peaked at 6 months of gestation (median: 4500 cells/liter, IQR: 333 to 2010000 cells/liter) among cases and 9 months (median: 6000 cells/liter, IQR: 667 to 386000 cells/liter) among controls. ![Figure 2:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/26/2022.10.24.22279447/F2.medium.gif) [Figure 2:](http://medrxiv.org/content/early/2022/10/26/2022.10.24.22279447/F2) Figure 2: Median *K. brevis* (cells/liter) exposure for cases and controls throughout gestation at a 50-mile radius. The distribution of maximum gestational *K. brevis* exposure at the 10-mile radius differed between cases and controls. Specifically, a greater proportion of controls had high *K. brevis* exposure (27.6%, n=42) in comparison to cases (18.4%, n=7) while a greater proportion of cases had no *K. brevis* exposure (63.2%, n=24) in comparison to controls (37.5%, n=57; *p*=.04). Maximum gestational *K. brevis* exposure at the 50-mile radius did not vary between cases and controls (*p*>.9). As seen in Figure 3a and 3b, when stratified by trimester, maximum *K. brevis* exposure at the 10- and 50-mile radius did not vary significantly between cases and controls (*p*≥ .05 for all). ![Figure 3:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/26/2022.10.24.22279447/F3.medium.gif) [Figure 3:](http://medrxiv.org/content/early/2022/10/26/2022.10.24.22279447/F3) Figure 3: Percentage of cases and controls exposed to *K. brevis* as stratified by exposure category at a 10- and 50-mile radius. Exposure categories defined as none if <1,000 cells/L, Low if ≥ 1,000 to 99,999 cells/L, medium if ≥100,000 to 999,999 cells/L and high if ≥ 1,000,000 cells/L. ### Association between *K. brevis* and biliary atresia Gender, race/ethnicity, coastal residence, and season of birth were observed as confounders of the relationship between *K. brev*is and BA according to the 10% criterion for confounding and were therefore included in the final multivariable models. As seen in Figure 4, there was not a statistically significant association between odds of BA and maximum *K. brevis* exposure per trimester at the 10- and 50-mile radius after adjustment for the aforementioned confounders. Notably, the direction of the adjusted odds ratio was less than one for all models except the second (OR: 3.2, CI: 0.5 to 20.4) and third trimester (OR:1.3, CI: 0.2 to 8.4) at the 50-mile radius. ![Figure 4:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/26/2022.10.24.22279447/F4.medium.gif) [Figure 4:](http://medrxiv.org/content/early/2022/10/26/2022.10.24.22279447/F4) Figure 4: Association between biliary atresia and maximum *K. brevis* exposure per pregnancy trimester at a 10- and 50-mile radius. ## DISCUSSION We evaluated whether an association between gestational *K. brevis* exposure and BA exists and observed no significant association using these data. The incidence of BA is increasing over time, with conflicting data regarding seasonality and risk factors 35,36. Our study did not account for the many proposed, yet not definitive, genetic, environmental or infectious confounders. Our cohort of patients did not demonstrate inter-group differences in birth seasonality, coastal residence or race/ethnicity; however, more cases were female. There are a number of caveats to the results we obtained. We used *K. brevis* levels at 10- and 50-mile radii, extrapolated from the zip code of primary residence, as a surrogate for brevetoxin exposure. Monitoring *K. brevis* levels alone may not be the optimal predictor of red tide toxin (brevetoxin) exposure 37, although it is generally accepted that *K. brevis* levels of less than 1,000 cells/Liter are considered background levels while levels greater than 100,000 cells/Liter are associated with respiratory symptoms in humans and mortality among murine wildlife 38. Brevetoxins have been detected in a variety of mammalian body fluids such as urine and serum using competitive enzyme-linked immuno-sorbent assay (competitive ELISA) 39. In humans, aerosolized brevetoxin has been quantified in scientific studies using an inhalable dust sampler and nasal swabs 40 though this is not routinely performed. *K. brevis* levels can fluctuate daily depending on various meteorological conditions such as temperature, wind speed, sunlight, and rainfall 41. Brevetoxins can be aerosolized at the wind/water interface and transported up to 6.4 km inland 32 and changes based on its concentration in the water, wind speeds and wind direction 42. There exist a variety of possible direct exposures to brevetoxins including the consumption of contaminated shellfish, fish or seawater 24. Patient-level exposure to *K. brevis* was extrapolated from exposure at the community level in monthly intervals, but the true degree of daily exposure to brevetoxin, whether by direct ingestion or inhalation, was not measured in this study and is not routinely measured in humans. Patients from inland zip codes may travel to the beaches at various time points during red tide, making their true exposure difficult to quantify. Additionally, it appears that even respiratory inhalation can result in systemic distribution that can be long lived as evidenced by intratracheal administration of brevetoxin to mice which led to variable absorption, though about 20% of the initial dose was retained in the lung, liver and kidney beyond 7 days 43. Among turtles, brevetoxin can be stored and accumulated in multiple organs and passed on to offspring through the egg yolk, showing that brevetoxins can affect marine wildlife even after a red tide bloom has dissipated 13. It remains unclear whether brevetoxins behave in a similar way in humans but may be worth studying further given the detrimental effects in murine wildlife. Overall, at a 10-mile radius from the zip code of residence, it appeared that our patient cohort had minimal exposure to *K. brevis* (cells/Liter) throughout gestation. Interestingly, at a 50-mile radius, the median gestational exposure for cases peaked at 6 months while for controls the peak occurred at 9 months. Recent studies explore the influence of early in utero events and the development of BA 36, and so it is worth noting that the timing of a toxic insult may be more important than absolute exposure. In Southwest Florida, there is an annual fluctuation in the incidence of red tide blooms. Owing to the increasing severity of red tide over time, there is mounting concern for human contribution through water pollution carrying industrial effluents, organic pollutants, and excess nutrients on which *K. brevis* algae thrive 25. It is suggested that increasing water temperatures through climate change may exacerbate red tide 44. This study is unique in its targeted assessment of a specific, biologically plausible, environmental toxin and its association with BA, and though none was found using the study methodology, further studies quantifying brevetoxin levels in maternal and neonatal biological samples could be useful in determining association with disease. Continued inquiry into other environmental toxins and pollutants as a potential cause of BA is needed. The lack of a significant association between K brevis exposure and development of BA must be carefully interpreted in the context of the limitations inherent to its design as a case control study. Controls were selected after an independent review of the electronic medical record and patients were excluded if they had any documented significant congenital anomalies, however, such diagnoses may exist outside of the documentation available within our hospital network. It is possible that certain common pediatric respiratory diagnoses may be aggravated by red tide toxin and may have been included in the control group; therefore, a large number of controls were selected to mitigate this potential risk. As a specialized children’s hospital, we serve a local area with multiple affiliates, however, patients with BA may have been diagnosed and treated elsewhere and thus, not captured in our study population. Additionally, as a single-institutional experience, our patient population may not be generalizable. ## CONCLUSIONS In the population studied, there was no statistically significant association between gestational exposure of *K. brevis* (cells/Liter) at the 10- and 50-mile radius from the zip code of residence and increased odds of diagnosis with BA. Further studies into environmental factors or toxins are needed to elucidate the multifactorial pathophysiology of this complex disease. ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## CONFLICTS OF INTEREST AND SOURCES OF FUNDING None declared ## ACKNOWLEDGEMENTS We thank the Florida Fish and Wildlife Conservation Commission for graciously sharing their detailed records of red tide levels. ## Footnotes * (jamie{at}jhmi.edu) (rgwells{at}pennmedicine.upenn.edu) (jmachry1{at}jhmi.edu) (skarjoo1{at}jhmi.edu) * Received October 24, 2022. * Revision received October 24, 2022. * Accepted October 26, 2022. * © 2022, Posted by Cold Spring Harbor Laboratory This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/) ## References 1. 1.Kilgore A, Mack CL. Update on investigations pertaining to the pathogenesis of biliary atresia. Pediatr Surg Int. 2017;33(12):1233–1241 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00383-017-4172-6&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 2. 2.Bezerra JA, Wells RG, Mack CL, et al. Biliary atresia: Clinical and research challenges for the twenty-first century. Hepatology. 2018;68(3):1163–1173 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/hep.29905&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 3. 3.Wehrman A, Waisbourd-Zinman O, Wells RG. Recent advances in understanding biliary atresia. F1000Res. 2019;8:doi:10.12688/f1000research.16732.1. eCollection 2019 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.12688/f1000research.16732.1&link_type=DOI) 4. 4.Estrada MA, Zhao X, Lorent K, et al. Synthesis and structure-activity relationship study of biliatresone, a plant isoflavonoid that causes biliary atresia. ACS Med Chem Lett. 2017;9(1):61–64 5. 5.Lorent K, Gong W, Koo KA, et al. Identification of a plant isoflavonoid that causes biliary atresia. Sci Transl Med. 2015;7(286):286ra67 [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6InNjaXRyYW5zbWVkIjtzOjU6InJlc2lkIjtzOjEzOiI3LzI4Ni8yODZyYTY3IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMTAvMjYvMjAyMi4xMC4yNC4yMjI3OTQ0Ny5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 6. 6.Fried S, Gilboa D, Har-Zahav A, et al. Extrahepatic cholangiocyte obstruction is mediated by decreased glutathione, wnt and notch signaling pathways in a toxic model of biliary atresia. Sci Rep. 2020;10(1):7599–020 7. 7.Lemaigre F, Zaret KS. Liver development update: New embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev. 2004;14(5):582–590 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.gde.2004.08.004&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15380251&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000224337700018&link_type=ISI) 8. 8.Roskams T, Desmet V. Embryology of extra- and intrahepatic bile ducts, the ductal plate. Anat Rec (Hoboken). 2008;291(6):628–635 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/ar.20710&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18484608&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 9. 9.Koo KA, Waisbourd-Zinman O, Wells RG, Pack M, Porter JR. Reactivity of biliatresone, a natural biliary toxin, with glutathione, histamine, and amino acids. Chem Res Toxicol. 2016;29(2):142–149 10. 10.Pack M, Wells RG. Toxins and biliary atresia. The Liver. 6th ed. 2020:1000–1006 11. 11.Tominack SA, Coffey KZ, Yoskowitz D, Sutton G, Wetz MS. An assessment of trends in the frequency and duration of Karenia Brevis red tide blooms on the South Texas coast (western Gulf of Mexico). PLoS ONE 15(9): e0239309 12. 12.Nam DH, Adams DH, Flewelling LJ, Basu N. Neurochemical alterations in lemon shark (negaprion brevirostris) brains in association with brevetoxin exposure. Aquat Toxicol. 2010;99(3):351–359 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20542580&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 13. 13.Perrault JR, Bauman KD, Greenan TM, Blum PC, Henry MS, Walsh CJ. Maternal transfer and sublethal immune system effects of brevetoxin exposure in nesting loggerhead sea turtles (caretta caretta) from western florida. Aquat Toxicol. 2016;180:131–140 14. 14.Whitney PL, Delgado JA, Baden DG. Complex behavior of marine animal tissue extracts in the competitive binding assay of brevetoxins with rat brain synaptosomes. Nat Toxins. 1997;5(5):193–200 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9496378&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 15. 15.Rodriguez FA, Escobales N, Maldonado C. Brevetoxin-3 (PbTx-3) inhibits oxygen consumption and increases Na+ content in mouse liver slices through a tetrodotoxin-sensitive pathway. Toxicon. 1994;32(11):1385–1395 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=7886697&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 16. 16.Cattet M, Geraci JR. Distribution and elimination of ingested brevetoxin (PbTx-3) in rats. Toxicon. 1993;31(11):1483–1486 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=8310449&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 17. 17.Fire SE, Leighfield TA, Miller GA, Piwetz S, Sabater ER, Whitehead H. Association between red tide exposure and detection of corresponding neurotoxins in bottlenose dolphins from texas waters during 2007-2017. Mar Environ Res. 2020;162:105191 18. 18.Naar JP, Flewelling LJ, Lenzi A, et al. Brevetoxins, like ciguatoxins, are potent ichthyotoxic neurotoxins that accumulate in fish. Toxicon. 2007;50(5):707–723 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17675204&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 19. 19.Twiner MJ, Flewelling LJ, Fire SE, et al. Comparative analysis of three brevetoxin-associated bottlenose dolphin (tursiops truncatus) mortality events in the florida panhandle region (USA). PLoS One. 2012;7(8):e42974 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0042974&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22916189&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 20. 20.Benson JM, Hahn FF, Tibbetts BM, et al. Florida red tide: Inhalation toxicity of karenia brevis extract in rats. Harmful Algae 2002 (2002). 2004;10:502–504 21. 21.Castle KT, Flewelling LJ, Bryan J, et al. Coyote (canis latrans) and domestic dog (canis familiaris) mortality and morbidity due to a karenia brevis red tide in the gulf of mexico. J Wildl Dis. 2013;49(4):955–964 22. 22.Fauquier DA, Flewelling LJ, Maucher JM, et al. Brevetoxicosis in seabirds naturally exposed to karenia brevis blooms along the central west coast of florida. J Wildl Dis. 2013;49(2):246–260 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.7589/2011-09-270&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23568900&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 23. 23.Fauquier DA, Flewelling LJ, Maucher J, et al. Brevetoxin in blood, biological fluids, and tissues of sea turtles naturally exposed to karenia brevis blooms in central west florida. J Zoo Wildl Med. 2013;44(2):364–375 24. 24.Flewelling LJ, Naar JP, Abbott JP, et al. Brevetoxicosis: Red tides and marine mammal mortalities. Nature. 2005;435(7043):755–756 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/nature435755a&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15944690&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000229638700036&link_type=ISI) 25. 25.Pierce RH, Henry MS. Harmful algal toxins of the florida red tide (karenia brevis): Natural chemical stressors in south florida coastal ecosystems. Ecotoxicology. 2008;17(7):623–631 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10646-008-0241-x&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18758951&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000259514300008&link_type=ISI) 26. 26.Bossart GD, Baden DG, Ewing RY, Roberts B, Wright SD. Brevetoxicosis in manatees (trichechus manatus latirostris) from the 1996 epizootic: Gross, histologic, and immunohistochemical features. Toxicol Pathol. 1998;26(2):276–282 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/019262339802600214&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9547868&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000072657000014&link_type=ISI) 27. 27.Rolton A, Soudant P, Vignier J, et al. Susceptibility of gametes and embryos of the eastern oyster, crassostrea virginica, to karenia brevis and its toxins. Toxicon. 2015;99:6–15 28. 28.Kimm-Brinson KL, Ramsdell JS. The red tide toxin, brevetoxin, induces embryo toxicity and developmental abnormalities. Environ Health Perspect. 2001;109(4):377–381 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11335186&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000168413600028&link_type=ISI) 29. 29.Kirkpatrick B, Fleming LE, Backer LC, et al. Environmental exposures to florida red tides: Effects on emergency room respiratory diagnoses admissions. Harmful Algae. 2006;5(5):526–533 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20357898&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 30. 30.Fleming LE, Kirkpatrick B, Backer LC, et al. Aerosolized red-tide toxins (brevetoxins) and asthma. Chest. 2007;131(1):187–194 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1378/chest.06-1830&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17218574&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000243548100029&link_type=ISI) 31. 31.Hoagland P, Jin D, Beet A, et al. The human health effects of florida red tide (FRT) blooms: An expanded analysis. Environ Int. 2014;68:144–153 32. 32.Kirkpatrick B, Pierce R, Cheng YS, et al. Inland transport of aerosolized florida red tide toxins. Harmful Algae. 2010;9(2):186–189 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20161504&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 33. 33.Walsh PJ, Bookman RJ, Zaias J, et al. Toxicogenomic effects of marine brevetoxins in liver and brain of mouse. Comp Biochem Physiol B Biochem Mol Biol. 2003;136(2):173–182 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S1096-4959(03)00223-9&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=14529743&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 34. 34.Leighfield TA, Muha N, Ramsdell JS. Tissue distribution of amino acid- and lipid-brevetoxins after intravenous administration to C57BL/6 mice. Chem Res Toxicol. 2014;27(7):1166–1175 35. 35.Hopkins PC, Yazigi N, Nylund CM. Incidence of biliary atresia and timing of hepatoportoenterostomy in the united states. J Pediatr. 2017;187:253–257 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jpeds.2017.05.006&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=28746031&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 36. 36.Cavallo L, Kovar EM, Aqul A, et al. The epidemiology of biliary atresia: Exploring the role of developmental factors on birth prevalence. J Pediatr. 2022 37. 37.Fire S, Miller G, Sabater E, Wells R. Utility of red tide (karenia brevis) monitoring data as a predictive tool to estimate brevetoxin accumulation in live, free-ranging marine mammals 38. 38.Stumpf RP, Li Y, Kirkpatrick B, et al. Quantifying karenia brevis bloom severity and respiratory irritation impact along the shoreline of southwest florida. PLOS ONE. 2022;17(1):e0260755 39. 39.Naar J, Weidner A, Baden DG. Competitive ELISA: An accurate, quick and effective tool to monitor brevetoxins in environmental and biological sample. Harmful Algae 2002 (2002). 2004;10:291–293 40. 40.Cheng YS, Zhou Y, Naar J, et al. Personal exposure to aerosolized red tide toxins (brevetoxins). J Occup Environ Hyg. 2010;7(6):326–331 [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20379895&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 41. 41.Huang J, Liu H, Yin K. Effects of meteorological factors on the temporal distribution of red tides in Tolo Harbour, Hong Kong. Mar Pollut Bull. 2018;126:419–427 42. 42.Cheng YS, Zhou Y, Irvin CM, et al. Characterization of marine aerosol for assessment of human exposure to brevetoxins. Environ Health Perspect. 2005;113(5):638–643 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1289/ehp.7496&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15866777&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000228962400048&link_type=ISI) 43. 43.Tibbetts BM, Baden DG, Benson JM. Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation. J Toxicol Environ Health A. 2006;69(14):1325–1335 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/15287390500360091&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16760139&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F26%2F2022.10.24.22279447.atom) 44. 44.Alcock F. An Assessment of Florida Red Tide: Causes, Consequences and Management Strategies. Technical Report. 2007. Available at: [https://mote.org/media/uploads/files/MPI\_RedTideAssessment-2007-Final.pdf](https://mote.org/media/uploads/files/MPI_RedTideAssessment-2007-Final.pdf). Accessed: October 24, 2022.